Immunovant Stock Investor Trims Stake, Still Bullish
Immunovant stock surged about 30% after a fund trimmed its stake by roughly $3 million. This article explains why the...
Understand the reasons for choosing a retirement plan over a 401k. Make informed decisions for a secure retirement.
23,531 articlesImmunovant stock surged about 30% after a fund trimmed its stake by roughly $3 million. This article explains why the...
Regulators have signaled close scrutiny of a possible Paramount-Warner Bros. merger, threatening delays and potential...
Regulators revived a stalled pipeline, prompting questions for investors in Sable Offshore. This guide breaks down wh...
Crypto markets are cooling as macro policy tightens and Bitcoin stalls on a breakout. This combination has led to a d...
A Seattle-area clinic is adopting a stark, device-free recovery model for tech addiction, with detox programs lasting...
Nike remains a heavyweight in athletic wear, but its stock has faced pressure. This guide breaks down whether should ...
Take-Two’s leader is steering a record $1.5 billion bet on GTA VI, illustrating how blockbuster launches shape person...
Two strong players define today’s clean energy stock face-off. This guide breaks down how Bloom Energy and Brookfield...
Canaccord Genuity boosts its price target on Plug Power to $4, citing early wins from Project Quantum Leap. The firm ...
XRP has long been tied to a grand bridge-currency dream. This article presents a bull case that even skeptics should ...
Portfolio manager Ben Carlson argues that avoiding big-ticket upgrades can shield households and portfolios from infl...
UiPath faced a cautious session as its Korea cloud launch tests regional demand. This article breaks down what happen...